A multicenter study to evaluate the disease burden and health economics of inpatients with multiple sclerosis in China
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A multicenter study to evaluate the disease burden and health economics of inpatients with multiple sclerosis in China
Authors
Keywords
Multiple sclerosis, Disease burden, Health economics, Disability-adjusted life years
Journal
Multiple Sclerosis and Related Disorders
Volume 60, Issue -, Pages 103732
Publisher
Elsevier BV
Online
2022-03-09
DOI
10.1016/j.msard.2022.103732
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Factors associated with the healthcare expenditures of patients with multiple sclerosis in urban areas of China estimated by a generalized estimating equation
- (2020) Yaling Du et al. Expert Review of Pharmacoeconomics & Outcomes Research
- 60/30: 60% of the Morbidity-Associated Multiple Sclerosis Disease Burden Comes From the 30% of Persons With Higher Impairments
- (2020) Marco Kaufmann et al. Frontiers in Neurology
- Economic burden of smoking-attributable diseases in China: A systematic review
- (2020) Lili Shi et al. Tobacco Induced Diseases
- Clinical Presentations and Phenotypic Spectrum of Multiple Sclerosis at a University Hospital in Saudi Arabia
- (2018) Saima Nazish et al. Journal of Clinical Neurology
- Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria
- (2018) Alan J Thompson et al. LANCET NEUROLOGY
- Global, regional, and national disability-adjusted life-years (DALYs) for 359 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017
- (2018) Hmwe Hmwe Kyu et al. LANCET
- Economics and Cost-Effectiveness of Multiple Sclerosis Therapies in the USA
- (2017) Daniel M. Hartung Neurotherapeutics
- Pathophysiology, assessment and management of multiple sclerosis fatigue: an update
- (2016) Mariarosa Rottoli et al. Expert Review of Neurotherapeutics
- Estimating epidemiological data of Multiple sclerosis using hospitalized data in Shandong Province, China
- (2016) Xiao Liu et al. Orphanet Journal of Rare Diseases
- Pathophysiology, assessment and management of multiple sclerosis fatigue: an update
- (2016) Mariarosa Rottoli et al. Expert Review of Neurotherapeutics
- The indirect costs of multiple sclerosis: systematic review and meta-analysis
- (2015) Ewa Stawowczyk et al. Expert Review of Pharmacoeconomics & Outcomes Research
- The Patient Protection and Affordable Care Act and Chronic Neurological Illnesses
- (2015) Gregory J. Esper et al. JAMA Neurology
- Treatment strategies for multiple sclerosis: When to start, when to change, when to stop?
- (2015) Alberto Gajofatto et al. World Journal of Clinical Cases
- Incidence, Prevalence, Costs, and Impact on Disability of Common Conditions Requiring Rehabilitation in the United States: Stroke, Spinal Cord Injury, Traumatic Brain Injury, Multiple Sclerosis, Osteoarthritis, Rheumatoid Arthritis, Limb Loss, and Back Pain
- (2014) Vincent Y. Ma et al. ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION
- Review of the pharmacoeconomics of early treatment of multiple sclerosis using interferon beta
- (2013) Florian Castrop et al. Neuropsychiatric Disease and Treatment
- The cost burden of multiple sclerosis in the United States: a systematic review of the literature
- (2013) Gabriel Adelman et al. JOURNAL OF MEDICAL ECONOMICS
- Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010
- (2012) Christopher J L Murray et al. LANCET
- Pathology of Demyelinating Diseases
- (2011) Bogdan F.Gh. Popescu et al. Annual Review of Pathology-Mechanisms of Disease
- The Cost of Disability and Medically Related Absenteeism Among Employees with Multiple Sclerosis in the US
- (2010) Jasmina I. Ivanova et al. PHARMACOECONOMICS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started